• Home
• firm shape
• Seattle biotech firm Shape Therapeutics inks gene therapy deal

Seattle biotech firm Shape Therapeutics inks gene therapy deal

5 (291) · $ 6.50 · In stock

Shape Therapeutics has signed a deal potentially exceeding $3 billion with pharma giant Roche to support the development of gene therapies for Alzheimer’s

Gene therapy - Wikipedia

Fierce Biotech's 2022 Fierce 15

Shape Therapeutics Inc.

NextGen Class of 2024: Top Life Sciences Startups to Watch This

Collaboration Deals in Biotechnology

The challenges and trends of cell & gene therapies - Drug

Cell and Gene Therapy Business Outlook

White House cybersecurity summit to include 's Andy Jassy, Microsoft's Satya Nadella – GeekWire

Seattle biotech firm Shape Therapeutics inks gene therapy deal